This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hypertension is a major contributor to the global disease burden of cardiovascular and cerebrovascular disease. The aim of this study was to determine demographic and clinical factors associated with adherence to antihypertensive medication.
Methods
From August 2012 to February 2015, we recruited 1,523 Korean patients with hypertension who visited family physicians. The study was conducted in 24 facilities located in urban and metropolitan areas. Of these facilities, two were primary care clinics and 22 were level 2 or 3 hospitals. Adherence was assessed using the pill count method; a cut-off value of 80% was used as the criterion for good adherence. Sociodemographic and lifestyle factors were compared between the adherent and nonadherent groups using the chi-square test for categorical variables and t-test for continuous variables. Binary logistic regression analysis was performed with medication adherence as the outcome variable.
Results
Of the 1,523 patients, 1,245 (81.7%) showed good adherence to antihypertensive medication. In the multivariate logistic analysis, age ≥65 years, exercise, treatment in a metropolitan-located hospital, being on ≥2 classes of antihypertensive medication and concomitant medication for diabetes, and a family history of hypertension or cardiovascular diseases were associated with good adherence. Patients who had a habit of high salt intake were less adherent to medication.
Conclusion
Multiple classes of antihypertensive medications, concomitant medication, and exercise were associated with good adherence to antihypertensive medication, and high salt intake was associated with poor adherence to antihypertensive medication. These factors should be considered to improve hypertension control.
Hypertension is a major risk factor for the development of cardiovascular and cerebrovascular diseases such as stroke [1]. An estimated 22% of the world population over 18 years of age was affected by hypertension in 2014 [1]. According to the National Health and Nutrition Survey, Korea (2015), the prevalence of hypertension in the Korean population aged 30 years and above was 27.9%, and the prevalence among men (32.7%) was higher than that among women (23.1%) [2].
Treatment of hypertension includes antihypertensive medication as well as lifestyle modifications. Patients with uncontrolled blood pressure (BP) may need more than 1 antihypertensive medication. Studies have shown that a significant proportion of hypertensive patients fail to achieve target BP levels [3,4]. In China, only 30.3% of hypertensive patients in 2010 were estimated to have BP levels within their respective target range [5]. Poor adherence to antihypertensive medication is a major cause of poor BP control [6,7]. Adherence refers to the extent to which a patient adheres to the prescribed medication at the recommended dosage [8]. In a randomized control trial, the overall rate of discontinuation of antihypertensive medication at 6 months and 1 year was 20.3% and 28.5%, respectively [3]. The rate of discontinuation at 1 year varied from 29.4% to 64.1% depending on the class of antihypertensive medication used. Thus, it is important to identify factors that may influence adherence.
Although adherence to antihypertensive medication is an active area of clinical research [9,10], treatment adherence among patients who visit primary care physicians is not well characterized. Furthermore, studies that have examined adherence across multiple antihypertensive medications and in patients on concomitant treatment for other conditions have been limited. In this prospective cohort study, we sought to determine the sociodemographic and clinical factors that affect adherence to antihypertensive medication in patients who visit family medicine physicians.
METHODS
1. Study Participants
This was a prospective multicenter cohort study conducted in 24 facilities across Korea for a period of 30 months (August 2012 to February 2015). These facilities were located in metropolitan and urban areas. Of the 24 facilities, two were primary care clinics and 22 were level 2 or 3 hospitals. A total of 1,523 Korean patients with hypertension who visited primary physicians during this period were enrolled.
Eligible patients were selected by the physicians and counseled regarding the study objectives. All patients who consented to participate were recruited. Eligible patients were those who were ≥20 years of age at diagnosis and were prescribed angiotensin II receptor blockers (ARBs) for the first time. These included both newly treated hypertensive patients and those who were already on antihypertensive medication other than ARBs. Patients were considered newly treated if they had not received ARBs prior to their enrollment. ARB was prescribed either as monotherapy or was added to other classes of antihypertensive medication as multi-therapy due to poor BP control. We subcategorized the participants based on the number of classes of antihypertensive medication. If a patient was taking one pill containing two different classes of antihypertensive medication, it was recorded as 2 classes.
We included both loss to follow-up and an adherence ratio of <0.80 as poor adherence. Of 278 participants, 218 dropped out of the study and 60 had an adherence ratio of <0.80. The most common reason for study drop out was loss to follow-up. Of the 218 participants who dropped out, 191 did not return to the clinic for follow-up prescriptions, 14 declined to take the medicine, eight had an adverse response to the medication (e.g., leg edema, headache, insomnia, dizziness, and hypotension), and five dropped out due to lack of effect.
2. Study Questionnaire
Data were collected using structured questionnaires. The questionnaires were used to obtain information on sociodemographic variables, lifestyle habits, comorbid conditions, family history of hypertension and diabetes, and number of classes of antihypertensive drugs prescribed. The numbers of prescribed and residual pills were counted and recorded at every visit.
Patient age at baseline was determined based on the date of birth registered in medical records. Body mass index (BMI) was calculated using the following formula: weight/height2. Patients were stratified into three groups based on BMI: BMI <23.0 kg/m2; 23.0–24.9 kg/m2; and >25.0 kg/m2. According to monthly income, patients were stratified into three groups: >8; 4–7.9; and <4 in million Korean won (KRW, also equivalent to 1,000 US dollars).
Participants consuming alcohol were divided into three groups: non-drinker; moderate drinker; and high-risk drinker. Moderate drinker implied the consumption of 8 glasses of alcohol or less per week for men. For women and men aged >65 years, moderate drinker implied the consumption of 4 glasses or less per week. One standard glass contains 14 g of alcohol that is equivalent to 1 bottle of beer (approximately 350–360 mL) or 500 mL of draft beer; 1/4 bottle of ‘soju’; and 1 glass (approximately 45 mL) of hard liquor [11]. ‘High-risk drinker’ referred to patients who consumed more than 8 glasses of alcohol per week for men. For both women and men aged >65 years, ‘high-risk drinker’ referred to patients who consumed more than 4 glasses of alcohol per week.
Salt usage behavior was evaluated using three validated questionnaires: “Do you usually eat salty?”; “Do you add salt or soy sauce to cooked dishes?”; and “Do you eat pan-fried or deep-fried food with soy sauce?” [12] The scoring criteria used in the first questionnaire were: very salty=12; a little salty=9; modestly salty=6; little salty=3; and not salty=0. For the second questionnaire, the scoring criteria were: always=12; frequently=8; seldom=4; and never=0. For the third questionnaire, the scoring criteria were: always=12; sometimes=6; and never=0. A total score of >18 for men and >16 for women was defined as high salt usage behavior [12,13]. Concomitant medication was assessed as per medications taken by the patient at the time of the survey.
3. Definition of Good and Poor Adherence
For measurement of adherence, we used the pill count data. Pill count is the indirect, objective measurement of adherence. The pill count method can be used to assess adherence in case of tablets, capsules, and actuated inhalers [14]. We counted the number of tablets that were taken between two clinic visits and compared it with the total number of tablets prescribed to calculate the adherence ratio. The period of time between clinical visits was different for each patient. For each clinical visit, we used the following formula for the calculation of adherence rates: [15] adherence ratio (%)={(number of prescribed pills–number of residual pills)/number of prescribed pills}×100.
The cutoff value for differentiating adherence and nonadherence was set arbitrarily [14].
In our study, the cut-off value for good adherence was set at 80%, which is commonly used in health research [10]. Adherence was calculated only for antihypertensive medications, and concomitant medication, such as for diabetes or dyslipidemia, were not taken into account. A cut-off value of 80% or above was considered good adherence. An adherence ratio of <80%, or a patient not attending the follow-up appointment, were considered indicative of poor adherence.
4. Statistical Analysis
Data were analyzed using IBM SPSS Statistics ver. 24.0 (IBM Corp., Armonk, NY, USA). Comparisons of demographic and lifestyle factors between adherent and nonadherent groups were analyzed using the chi-square test for categorical variables and t-test for continuous variables.
Binary logistic regression analysis was performed with medication adherence as the outcome variable. Logistic regression analyses were performed to identify correlates of adherence, and the associated odds ratios (OR) and 95% confidence intervals (CI) were calculated. Only significant covariates (P<0.05) identified on univariate analysis were included in the multivariate logistic regression analysis. A P-value of <0.05 was considered statistically significant.
RESULTS
1. Participant Characteristics
Table 1 presents the baseline characteristics of the study population (N=1,523). Participants were predominantly male (59.6%), married (88.1%), and had a monthly income that ranged from 4 to 7.9 million KRW (52.4%). Over half the participants (52.7%) were obese (BMI ≥25.0 kg/m2). The majority of the hypertensive participants (43.1%) were in the age-group of 50–64 years. Overall, 17.3% were current smokers and 23.3% were high-risk drinkers. A total of 699 patients (59.7%) had a habit of high salt usage. Overall, 761 patients (50.0%) were on ARB monotherapy, 550 (36.1%) were on dual therapy, and 212 (13.9%) were on multidrug therapy with ≥3 classes of antihypertensive medications. Approximately 24.9% and 51.4% of patients were also receiving medication for diabetes and dyslipidemia, respectively. A total of 104 participants had concomitant disease such as coronary artery disease (42, 2.8%), cerebral vascular disease (53, 3.5%), and vascular disease involving major arteries (19, 1.2%). The types of clinics where patients were treated were primary care clinics, secondary hospitals (537, 35.3%), and tertiary hospitals (986, 64.7%). The clinics where patients were treated were mostly located in metropolitan (1,075, 70.6%) areas; the remaining patients received treatment in urban areas (448, 29.4%).
2. Comparison of Sociodemographic, Lifestyle, and Disease-Related Factors for Good and Poor Adherence
Of the 1,523 participants, 1,245 (81.7%) showed good adherence to antihypertensive medication, while 278 (18.3%) showed poor adherence (Table 2). The duration of follow-up for each participant was different between both groups. For patients who showed good adherence to antihypertensive medication, the mean follow-up duration was 181.9±83.5 days, and for those with poor adherence, the follow-up duration was 190.9±83.5 days (P=0.287). Age, monthly income, location of clinic where patients were treated, exercise, habit of salt intake, classes of antihypertensive medication, concomitant medication for diabetes or dyslipidemia, and family history of hypertension or cardiovascular disease were significantly associated with adherence (P<0.05).
3. Predictors of Medication Adherence
The variables listed in Tables 3 and 4 were assessed for their association with good adherence to antihypertensive medication. Binary logistic regression was performed with adjustment for age and sex. Variables that showed a significant association with adherence were included in the multivariate logistic regression analysis as candidate variables. After adjustment for relevant baseline factors, participants who were ≥65 years of age (OR, 1.83; 95% CI, 1.18–2.83), who were treated at a metropolitan-located hospital (OR, 1.86; 95% CI, 0.78–2.36), and who exercised 1–2 times (OR, 1.43; 95% CI, 1.02–2.01) or ≥3 times (OR, 1.57; 95% CI, 1.12–2.20) per week showed good adherence (Table 3).
On multivariate logistic regression analysis of disease-related factors after adjustment for age, sex, monthly income, and exercise (Table 4), treatment with 2 classes (OR, 1.55; 95% CI, 1.14–2.12) and ≥3 classes of antihypertensive medication (OR, 3.82; 95% CI, 2.06–7.10), concomitant treatment for diabetes (OR, 1.67; 95% CI, 1.16–2.40) or dyslipidemia (OR, 1.48; 95% CI, 1.12–1.97), and family history of hypertension (OR, 1.72; 95% CI, 1.29–2.30), or cardiovascular disease (OR, 1.70; 95% CI, 1.21–2.39) were significantly associated with good adherence. Patients who had a habit of high salt intake were less adherent to antihypertensive medication (OR, 0.64; 95% CI, 0.48–0.67).
DISCUSSION
Of the 1,523 participants in the present study, 1,245 (81.7%) showed good adherence to antihypertensive therapy. Patients who were ≥65 years of age, who were treated at a metropolitan hospital, and those who exercised ≥1 time per week showed good adherence to antihypertensive medication. However, patients with a high salt intake were less adherent to medication. Patients with good adherence were more likely to be on ≥2 classes of antihypertensive medication and concomitant medication for diabetes and dyslipidemia and were likely to have a family history of hypertension or cardiovascular disease.
The adherence rate was higher than that reported in previous studies in China (51.7%) and the United States (67.6%) [16,17]. Because our study was conducted primarily in level 2 or 3 hospitals, which enrolled participants with relatively higher income and education status than the average Korean adults, this could account for a higher adherence rate [17]. Older age was shown to be associated with better treatment adherence among hypertensive patients due to perceived susceptibility and severity of the disease [18-20]. Although most studies are conducted based on the residence of patients, the finding in this study suggests that a regional barrier of heath care provision between urban and metropolitan areas may affect medication adherence [21]. Medical services are focused around metropolitan areas, which may enhance competition between clinics to provide better services for patients. We suggest that this positively affected medication adherence in patients who were treated in metropolitan rather than in urban clinics.
In our study, patients with high salt intake showed poor adherence to antihypertensive medication. In an observational study conducted in India [22], poor adherence to treatment was noted in persons with unrestricted dietary habits and a high salt intake of >5 mg per day. According to another study [20], among patients who were treated for both diabetes and hypertension by family physicians, those who exercised regularly or had a healthy diet with a low salt intake or both were more likely to have good adherence to medication. These results suggest that interventions aimed at lifestyle modification can reinforce good adherence to medications.
Known cardiovascular risk factors (i.e., diabetes mellitus and dyslipidemia) showed a significant association with good adherence to antihypertensive medications; this is consistent with a previous study [23]. The association of a family history of hypertension or cardiovascular disease with adherence has also been shown in other studies [23,24]. Patients with concomitant comorbid conditions, especially those related to cardiovascular risk factors, are more likely to be aware of being at a higher risk and, therefore, more likely to adhere to a therapeutic regimen [23].
A previous descriptive study showed a positive association between adherence and the number of pills [25]. This association is consistent with that observed in our study, although in our study, we analyzed the variable disaggregated by the number of classes of antihypertensive medication rather than by the number of antihypertensive drugs. It could be partially explained by the possibility that patients who are prescribed multiple pills tend to be more motivated to take medications due to the perception of the severity of the disease [25]. A second explanation may be that patients who are prescribed multiple medications daily are less likely to forget them compared to those prescribed only 1 pill [25]. Moreover, as patients may visit family physicians more frequently for medication refills, this may strengthen adherence [20].
There were several limitations in this study. First, our population may not reflect the general population of Korea as baseline demographic characteristics show that participants were relatively educated with high income. However, patients were recruited from various hospitals and different areas of Korea, making the study population heterogeneous. Second, adherence was measured indirectly using the pill count method. The direct method includes measurement of the concentration of the drug or its metabolite in body fluids (i.e., urine or blood) or measurement of biological markers [14]. However, direct methods are expensive, invasive and can also induce bias if the patient only takes medication just before the upcoming test. Also the pill count method has been shown to be more accurate compared to other subjective methods [14]. Third, the habit of salt usage was evaluated using a questionnaire rather than a precise quantification of salt intake. However, dietary surveys require fewer resources and enable the identification of dietary sources of salt that can be used for public health interventions [26,27]. There are different patterns of sodium consumption in different populations. For instance, in Western countries, most intake is from sodium content in processed food [26], but in some countries such as Korea, most of the salt is added during cooking through salt or sauce or added at the time of consumption. Dietary questionnaires may better reflect this pattern of salt usage behavior. Moreover, in a study conducted in Australia [28], a scored sodium questionnaire showed a significant correlation with 24-hour urine sodium. Fourth, we only included sociodemographic and lifestyle factors, whereas other factors such as patient, provider, family context, social or occupational conditions, and health system can have effect on adherence. Fifth, inherent in every observational study, there may have been residual confounding effects due to unmeasured or unrecorded factors.
This study has several strengths. First, the number of participants included in this study is large. Consequently, the results of our study seem notable. Second, participants of this study were recruited from various facilities by primary care physicians. Thus, the findings of the present study may be applied in family medicine clinical situation.
In conclusion, patients who showed good adherence to antihypertensive medication were on ≥2 classes of antihypertensive medication and other concomitant medications such as those for diabetes and dyslipidemia. High salt intake was associated with lower adherence. Among these factors, salt intake and exercise are modifiable factors. As such, we may employ these findings to identify patients who are less likely to adhere to medication for those who visit family medicine physicians to enhance adherence to medication.
Notes
No potential conflict of interest relevant to this article was reported.
ACKNOWLEDGMENTS
This study was supported in part by the Daiichi Sankyo Company in Korea.
Table 1.
Baseline characteristics of the study population (n=1,523)
*Monthly income in million KRW or 1,000 US dollar.
†Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for women and men over 65 years of age.
‡Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12); high intake was defined as a total score ≥18 for men and ≥16 for women.
Table 2.
Comparison of demographic and lifestyle factors between the adherent and nonadherent groups
*Adherence was calculated using the pill count method. Adherence ratio (%)={(number of prescribed pills−number of residual pills)/number of prescribed pills}×100. We defined good and poor adherence as an adherence ratio ≥0.80 and <0.80, respectively.
†P-values calculated using the t-test for continuous variables or the chi-square test for categorical variables.
‡Monthly income in million KRW or 1,000 US dollars.
§Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for women and men over 65 years of age.
∥Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12) and high intake was defined as a total score ≥18 for men and ≥16 for women.
Table 3.
Association of sociodemographic and lifestyle factors with adherence to antihypertensive medication
*Logistic regression analysis was conducted after adjusting for age, sex, monthly income, and exercise frequency.
†Monthly income in million KRW or 1,000 US dollars.
‡Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for woman and men over 65 years of age.
Table 4.
Association between hypertension-related factors and adherence to antihypertensive medication
OR, odds ratio; CI, confidence interval; Ref, reference.
*Logistic regression analysis adjusted for age, sex, monthly income, and exercise frequency.
†Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12). High intake was defined as a total score of ≥18 for men and ≥16 for women.
References
1. World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
2. Korea Centers for Disease Control and Prevention. Korean health statistics 2014; National Health and Nutrition Survey. Cheongju: Korea Centers for Disease Control and Prevention; 2015.
3. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006;24:1193-200.
4. Moon JY, Park KJ, Hwangbo Y, Lee MR, Yoo BI, Won JH, et al. A trend analysis of the prevalence, awareness, treatment, and control of hypertension by age group. J Prev Med Public Health 2013;46:353-9.
5. Wu L, He Y, Jiang B, Sun D, Wang J, Liu M, et al. Trends in prevalence, awareness, treatment and control of hypertension during 2001-2010 in an urban elderly population of China. PLoS One 2015;10:e0132814.
9. Kim HJ, Moon K, Park TH, Park SY, Yoon SJ, Oh IH. Factors affecting treatment compliance in new hypertensive patients in Korea. Clin Exp Hypertens 2016;38:701-9.
11. Kim JS. Management of drinking patients in primary care. Korean J Fam Pract 2012;2:280-8.
12. Kim HJ, Paik HY, Lee SY, Shim JE, Kim YS. Salt usage behaviors are related to urinary sodium excretion in normotensive Korean adults. Asia Pac J Clin Nutr 2007;16:122-8.
13. Lee JA, Kim WS, Bae MJ, Kim YS, Oh HJ, Lee SY, et al. The effectiveness of short term mobile phone text reminders in improving compliance among hypertensive patients. Korean J Health Promot 2014;14:1-8.
15. Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, et al. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study. QJM 2013;106:909-14.
17. Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence. J Eval Clin Pract 2015;21:166-72.
18. Kamran A, Sadeghieh Ahari S, Biria M, Malepour A, Heydari H. Determinants of patient’s adherence to hypertension medications: application of health belief model among rural patients. Ann Med Health Sci Res 2014;4:922-7.
19. Kang CD, Tsang PP, Li WT, Wang HH, Liu KQ, Griffiths SM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol 2015;182:250-7.
20. Natarajan N, Putnam W, van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician 2013;59:e93-e100.
21. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol 2008;128:392-8.
22. Venkatachalam J, Abrahm SB, Singh Z, Stalin P, Sathya GR. Determinants of patient’s adherence to hypertension medications in a rural population of Kancheepuram district in Tamil Nadu, South India. Indian J Community Med 2015;40:33-7.
23. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-605.
24. Mallya SD, Kumar A, Kamath A, Shetty A, Mishra S. Assessment of treatment adherence among hypertensive patients in a coastal area of Karnataka, India. Int J Community Med Public Health 2017;3:1998-2003.
25. Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One 2007;2:e280.
27. Hawkes C, Webster J. National approaches to monitoring population salt intake: a trade-off between accuracy and practicality? PLoS One 2012;7:e46727.
28. Mason B, Ross L, Gill E, Healy H, Juffs P, Kark A. Development and validation of a dietary screening tool for high sodium consumption in Australian renal patients. J Ren Nutr 2014;24:123-34.
Analysis of Adherence Status and Influencing Factors Among Middle‐Aged and Elderly Hypertension Patients in Rural Areas of Northeast China Xinyuan Lu, Jiwei Wang, Sikun Chen, Lin Lv, Jinming Yu, Peng Geng International Journal of Hypertension.2025;[Epub] CrossRef
Frequency of missed doses and its effects on the regulation of glucose levels in patients with type 2 diabetes: A retrospective analysis Megumi Shiomi, Tesshu Takada, Katsuya Otori, Kiyoshi Shibuya Medicine.2024; 103(15): e37711. CrossRef
Non-adherence to appointment follow-up and its associated factors among hypertensive patients in follow-up clinics in South Gondar hospitals Gebrie kassaw Yirga, Getu Sisay Mekonen, Endalk Getasew Hiruy, Kirubel Shiferaw, Berihun Bantie Scientific Reports.2024;[Epub] CrossRef
Factors associated with suboptimal adherence to antihypertensive medication: Cross-sectional study using nationally representative databases Sangyong Jo, Taegyu Um, Jihye Shin, Dongchan Lee, Kyungil Park, Minkook Son Heliyon.2024; 10(19): e38531. CrossRef
Prevalence of antihypertensive medication adherence and associated factors in India: A systematic review and meta-analysis B. Pal, A. Dutta, V. Chaudhary, S. Kumari, S. Meenakshi, K. Murti Hipertensión y Riesgo Vascular.2024;[Epub] CrossRef
ОСОБЛИВОСТІ ПАЦІЄНТ-ОРІЄНТОВАНОГО СПІЛКУВАННЯ ІЗ ПАЦІЄНТОМ З АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ Д. О. Лагода Здобутки клінічної і експериментальної медицини.2024; (4): 39. CrossRef
Blood Pressure Profile and Factors Affecting Medication Adherence in Older Persons with Hypertension in Two Care Centers Chinonyerem O. Iheanacho, Agbaje Akeem Babatunde, Uchenna I. H. Eze Ageing International.2023; 48(3): 729. CrossRef
Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy Dmitrijs Kustovs, Inga Urtāne, Eduards Sevostjanovs, Eva Moreino, Kārlis Trušinskis Medicina.2023; 59(2): 340. CrossRef
Impact of health literacy and social support on medication adherence in patients with hypertension: a cross-sectional community-based study Aizhen Guo, Hua Jin, Jianbo Mao, Weihong Zhu, Ye Zhou, Xuhua Ge, Dehua Yu BMC Cardiovascular Disorders.2023;[Epub] CrossRef
Effectiveness of the Combination of Enalapril and Nifedipine for the Treatment of Hypertension versus Empirical Treatment in Primary Care Patients Humberto Badillo-Alonso, Marisol Martínez-Alanis, Ramiro Sánchez-Huesca, Abel Lerma, Claudia Lerma Journal of Cardiovascular Development and Disease.2023; 10(6): 243. CrossRef
Factors Influencing Medication Adherence in Elderly Patients with Hypertension: A Single Center Study in Western China Qiuyu Pan, Cheng Zhang, Lansicheng Yao, Chenyao Mai, Jinpeng Zhang, Zhitong Zhang, Jun Hu Patient Preference and Adherence.2023; Volume 17: 1679. CrossRef
The Development and Validation of the “Hippocratic Hypertension Self-Care Scale” Hero Brokalaki, Anastasia A. Chatziefstratiou, Nikolaos V. Fotos, Konstantinos Giakoumidakis, Evaggelos Chatzistamatiou Healthcare.2023; 11(18): 2579. CrossRef
Adherence Behaviors and Related Factors Among Elderly Hypertensive Patients in China: Evidence from the China Health and Retirement Longitudinal Study Fengyu Liu, Huajing Chang, Xiaojun Liu Patient Preference and Adherence.2023; Volume 17: 3539. CrossRef
Predictors of non-adherence to antihypertensive medications: A cross-sectional study from a regional hospital in Afghanistan Muhammad Haroon Stanikzai, Mohammad Hashim Wafa, Essa Tawfiq, Massoma Jafari, Cua Ngoc Le, Abdul Wahed Wasiq, Bilal Ahmad Rahimi, Ahmad Haroon Baray, Temesgen Anjulo Ageru, Charuai Suwanbamrung, Kahsu Gebrekidan PLOS ONE.2023; 18(12): e0295246. CrossRef
Burden of hypertension in Ghana – Analysis of awareness and screening campaign in the Ashanti Region of Ghana Elliot Koranteng Tannor, Obed Ofori Nyarko, Yaw Adu-Boakye, Saabea Owusu Konadu, Gilda Opoku, Frank Ankobea-Kokroe, Mercy Opare Addo, Evans Xorse Amuzu, Gilgal Justice Ansah, Kate Appiah-Boateng, Daniel Ansong JRSM Cardiovascular Disease.2022;[Epub] CrossRef
Antihypertensive medications adherence and associated uncontrolled blood pressure among hypertensive patients in Ethiopia: Systematic review and meta-analysis Melaku Desta, Desalegn Yibeltal, Peter Memiah, Temesgen Ayenew, Henok Mulugeta, Mihretie Gedefaw, Bekalu Bewket Kidanie, Molla Yigzaw Birhanu, Zenaw Tessema, Belayneh Mengist, Muluneh Alene, Muluye Molla Simieneh, Atsede Alle Ewunetie, Wondimeneh Shibabaw International Journal of Africa Nursing Sciences.2022; 16: 100404. CrossRef
Association of adherence measured by self-reported pill count with achieved blood pressure level in hypertension patients: a cross-sectional study Iin Ernawati, Eziah Ika Lubada, Ria Lusiyani, Rahmad Aji Prasetya Clinical Hypertension.2022;[Epub] CrossRef
Urban-Rural Difference in Treatment Adherence of Chinese Hypertensive Patients Jingjing Pan, Haizhen Yu, Bin Hu, Qiongge Li Patient Preference and Adherence.2022; Volume 16: 2125. CrossRef
Prevalence of Hypertension in Ghana: Analysis of an Awareness and Screening Campaign in 2019 Elliot Koranteng Tannor, Obed Ofori Nyarko, Yaw Adu-Boakye, Saabea Owusu Konadu, Gilda Opoku, Frank Ankobea-Kokroe, Mercy Opare-Addo, Lambert Tetteh Appiah, Evans Xorse Amuzu, Gilgal Justice Ansah, Kate Appiah-Boateng, Emmanuel Ofori, Daniel Ansong Clinical Medicine Insights: Cardiology.2022;[Epub] CrossRef
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta‐Analysis Involving 27 Million Patients Eric K. P. Lee, Paul Poon, Benjamin H. K. Yip, Yacong Bo, Meng‐Ting Zhu, Chun‐Pong Yu, Alfonse C. H. Ngai, Martin C. S. Wong, Samuel Y. S. Wong Journal of the American Heart Association.2022;[Epub] CrossRef
Assessment of Patients’ Views on Drug Benefits and Risks: An Interview Study with Cardiovascular Patients Ines Wakob, Ina Wintsche, Annett Frisch, Yvonne Remane, Ulrich Laufs, Thilo Bertsche, Susanne Schiek, Yigit Canga International Journal of Clinical Practice.2022; 2022: 1. CrossRef
Determinants of Adherence to Antihypertensives Among Elderly: A Multifactorial Concern Melita Sheilini, H Manjunatha Hande, Elsa Sanatombi Devi, Asha Kamath, Baby S Nayak, Donald E Morisky, Anice George Patient Preference and Adherence.2022; Volume 16: 3185. CrossRef
Factors related to treatment adherence among hypertensive patients: A cross-sectional study in primary healthcare centers in Taif city Mohammed A. Alsofyani, Adel O. Aloufi, Nada S. Al-Qhtani, Sarah O. Bamansour, Raghad S. Almathkori Journal of Family and Community Medicine.2022; 29(3): 181. CrossRef
Determining the Prevalence of and the Factors Associated with Antihypertensive Medication Non-Adherence in the Gaza Strip Khalid Khadoura, Elham Shakibazadeh, Mohammad Ali Mansournia, Yousef Aljeesh, Akbar Fotouhi Korean Journal of Family Medicine.2021; 42(2): 150. CrossRef
Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis Sajid Mahmood, Zahraa Jalal, Muhammad Abdul Hadi, Tahir Mehmood Khan, M. Sayeed Haque, Kifayat Ullah Shah International Journal of Clinical Pharmacy.2021; 43(3): 486. CrossRef
Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults With Hypertension Hokyou Lee, Yuichiro Yano, So Mi Jemma Cho, Ji Eun Heo, Dong-Wook Kim, Sungha Park, Donald M. Lloyd-Jones, Hyeon Chang Kim Hypertension.2021; 77(4): 1341. CrossRef
Medication Adherence and Effective Management of Hypertension Seung-Won Oh Korean Journal of Family Medicine.2021; 42(2): 89. CrossRef
Self-Care Practice and Associated Factors among Hypertensive Patients in Ethiopia: A Systematic Review and Meta-Analysis Adam Wondmieneh, Getnet Gedefaw, Addisu Getie, Asmamaw Demis, Kai Hu International Journal of Hypertension.2021; 2021: 1. CrossRef
Effects of morbidity on smoking cessation: a national smoking cessation program Young-Gyun Seo, Min-Woo Jo, Yu-Jin Paek, Jaekyung Choi Addiction Science & Clinical Practice.2021;[Epub] CrossRef
Behavioral Factors Associated with Medication Nonadherence in Patients with Hypertension Shu-Mei Chang, I-Cheng Lu, Yi-Chun Chen, Chin-Feng Hsuan, Yin-Jin Lin, Hung-Yi Chuang International Journal of Environmental Research and Public Health.2021; 18(18): 9614. CrossRef
Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study Ahmed Hussein, Mohammad Shafiq Awad, Hossam Eldin M. Mahmoud The Egyptian Heart Journal.2020;[Epub] CrossRef
Factors associated with nonadherence to antihypertensive medication among middle-aged adults with hypertension: findings from the Taiwan National Health Interview Survey Chia-Pei Chou, Chun-Yu Chen, Kun-Siang Huang, Shih-Chun Lin, Chih-Fang Huang, Malcolm Koo Journal of International Medical Research.2020;[Epub] CrossRef
Impact of satisfaction with physician–patient communication on self-care and adherence in patients with hypertension: cross-sectional study Natalia Świątoniowska-Lonc, Jacek Polański, Wojciech Tański, Beata Jankowska-Polańska BMC Health Services Research.2020;[Epub] CrossRef
Mediating Effect of Self-Efficacy on the Relationship Between Medication Literacy and Medication Adherence Among Patients With Hypertension Zhiying Shen, Shuangjiao Shi, Siqing Ding, Zhuqing Zhong Frontiers in Pharmacology.2020;[Epub] CrossRef
Influence of socio-demographic factors and length of disease on adherence of patients with arterial hypertension Marijana Jandrić-Kočič, Snežana Knežević Timocki medicinski glasnik.2020; 45(4): 140. CrossRef
Baixo Letramento em Saúde: uma realidade brasileira Josué Da Silva Brito, Christiano Tadeu Sanches Mattos Kilesse, Priscilla Itatianny De Oliveira Silva HU Revista.2020; 46: 1. CrossRef
Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT Catherine G. Derington, Tyler H. Gums, Adam P. Bress, Jennifer S. Herrick, Tom H. Greene, Andrew E. Moran, William S. Weintraub, Ian M. Kronish, Donald E. Morisky, Katy E. Trinkley, Joseph J. Saseen, Kristi Reynolds, Jeffrey T. Bates, Dan R. Berlowitz, Ta Hypertension.2019; 74(2): 267. CrossRef
Association Between Medication Literacy and Medication Adherence Among Patients With Hypertension Shuangjiao Shi, Zhiying Shen, Yinglong Duan, Siqing Ding, Zhuqing Zhong Frontiers in Pharmacology.2019;[Epub] CrossRef
Assessment of adherence to drug treatment and affecting factors among hypertensive patients Burkay YAKAR, Asli AZAKOGLU KARACA, Erhan ONALAN Family Practice and Palliative Care.2019; 4(3): 89. CrossRef
Medication Adherence in Korean Hypertensive Patients Young Gyu Cho Korean Journal of Family Medicine.2018; 39(6): 323. CrossRef
Factors Affecting Adherence to Antihypertensive Medication
Factors Affecting Adherence to Antihypertensive Medication
Characteristic
No. (%)
Age (y)
<50
322 (21.1)
50–64
657 (43.1)
≥65
544 (35.7)
Sex
Male
907 (59.6)
Female
616 (40.4)
Marital status
Single
178 (11.9)
Married
1,318 (88.1)
Monthly income* (million KRW)
≥8
254 (17.8)
4–7.9
746 (52.4)
<4
424 (29.8)
Education (y)
<12
353 (23.8)
12
567 (38.3)
>12
562 (37.9)
Type of clinic where patients were treated
Primary care clinic and secondary hospital
537 (35.3)
Tertiary hospital
986 (64.7)
Location of clinic where patients were treated
Urban
448 (29.4)
Metropolitan
1,075 (70.6)
Smoking
Ever smoker
739 (49.2)
Never smoker
762 (50.8)
Alcohol consumption†
Non-drinker
780 (54.2)
Moderate drinker
325 (22.6)
High-risk drinker
335 (23.3)
Exercise (per week)
No
496 (34.2)
1–2
435 (30.0)
≥3
518 (35.8)
Body mass index (kg/m2)
<23.0
317 (20.8)
23.0–24.9
358 (23.5)
≥25.0
802 (52.7)
Habit of high salt intake‡
No
600 (40.3)
Yes
888 (59.7)
Newly treated hypertension
Yes
760 (49.9)
No
763 (51.1)
No. of antihypertensive medication classes
1
761 (50.0)
2
550 (36.1)
≥3
212 (13.9)
Concomitant medication for diabetes
No
1,143 (75.0)
Yes
380 (25.0)
Concomitant medication for dyslipidemia
No
783 (51.4)
Yes
740 (48.6)
Characteristic
Good adherence* (N=1,245)
Poor adherence* (N=278)
P-value†
Age (y)
<50
252 (20.2)
70 (25.2)
<0.001
50–64
504 (40.5)
153 (55.0)
≥65
489 (39.3)
55 (19.8)
Sex
Male
731 (58.7)
176 (63.3)
0.158
Female
514 (41.3)
102 (36.7)
Marital status
Single
155 (12.6)
23 (8.6)
0.064
Married
1,073 (87.4)
245 (91.4)
Monthly income‡ (million KRW)
≥8
208 (17.8)
46 (17.9)
0.002
4–7.9
589 (50.5)
157 (61.1)
<4
370 (31.7)
54 (21.0)
Education (y)
<12
304 (25.0)
49 (18.4)
0.071
12
460 (37.8)
107 (40.2)
>12
452 (37.2)
110 (41.4)
Type of clinic where patients are treated
Primary care clinic and secondary hospital
428(34.6)
28(45.2)
0.089
Tertiary hospital
809 (65.4)
34 (54.8)
Location of clinic where patients were treated
Urban
395 (31.7)
53 (19.1)
<0.001
Metropolitan
850 (68.3)
225 (80.9)
Smoking
Ever smoker
609 (49.6)
130 (47.8)
0.600
Never smoker
620 (50.4)
142 (52.2)
Alcohol consumption§
Non-drinker
644 (54.7)
136 (51.7)
0.290
Moderate drinker
256 (21.8)
69 (26.2)
High-risk drinker
277 (23.5)
58 (22.1)
Exercise (per week)
0
380 (32.1)
116 (43.6)
0.001
1–2
360 (30.4)
75 (28.2)
≥3
443 (37.4)
75 (28.2)
Body mass index (kg/m2)
<23.0
255 (21.2)
60 (22.2)
0.407
23.0–24.9
301 (25.0)
57 (21.1)
≥25.0
649 (53.9)
153 (56.7)
Habit of high salt intake∥
No
518 (42.6)
82 (30.3)
<0.001
Yes
699 (57.4)
189 (69.7)
Newly treated hypertension
No
585 (47.0)
175 (62.9)
<0.001
Yes
660 (53.0)
103 (37.1)
No. of antihypertensive medication class
1
585 (47.0)
176 (63.3)
<0.001
2
461 (37.0)
89 (32.0)
≥3
199 (16.0)
13 (4.7)
Concomitant medication for diabetes
No
910 (73.1)
233 (83.8)
<0.001
Yes
335 (26.9)
45 (16.2)
Concomitant medication for dyslipidemia
No
617 (49.6)
166 (59.7)
0.002
Yes
628 (50.4)
112 (40.3)
Family history of hypertension
No
496 (40.3)
134 (49.8)
0.004
Yes
736 (59.7)
135 (50.2)
Family history of cardiovascular disease
No
865 (70.3)
214 (79.6)
0.002
Yes
366 (29.7)
55 (20.4)
Variable
Age, sex-adjusted
Multivariate*
OR (95% CI)
P-value
OR (95% CI)
P-value
Age (y)
<50
1 (Ref)
1 (Ref)
50–64
0.90 (0.65–1.25)
0.524
0.80 (0.56–1.13)
0.195
≥65
2.41 (1.63–3.57)
<0.001
1.83 (1.18–2.83)
0.007
Sex
Male
1 (Ref)
1 (Ref)
Female
1.09 (0.82–1.44)
0.565
1.05 (0.78–1.42)
0.742
Marital status
Single
1 (Ref)
1 (Ref)
Married
0.66 (0.41–1.04)
0.074
0.80 (0.50–1.29)
0.360
Monthly income† (million KRW)
≥8
1 (Ref)
1 (Ref)
4–7.9
0.78 (0.54–1.12)
0.181
0.81 (0.56–1.17)
0.262
<4
1.20 (0.76–1.88)
0.436
1.35 (0.85–2.14)
0.207
Education (y)
<12
1.00 (Ref.)
1.00 (Ref.)
12
0.83 (0.56–1.21)
0.326
0.79 (0.53–1.20)
0.270
>12
0.90 (0.59–1.36)
0.605
0.88 (0.56–1.63)
0.556
Type of clinic where patients were treated
Primary care clinic and secondary hospital
1 (Ref)
1 (Ref)
Tertiary hospital
1.55 (0.93–2.59)
0.096
1.35 (0.78–2.36)
0.289
Location of clinic where patients were treated
Urban
1 (Ref)
1 (Ref)
Metropolitan
1.90 (1.13–3.17)
0.015
1.86 (1.07–3.25)
0.029
Smoking
Ever smoker
1 (Ref)
1 (Ref)
Never smoker
0.701 (0.49–1.00)
0.051
0.72 (0.49–1.06)
0.095
Alcohol consumption‡
Non-drinker
1 (Ref)
1 (Ref)
Moderate drinker
0.96 (0.67–1.37)
0.816
0.93 (0.64–1.35)
0.691
High-risk drinker
1.31 (0.89–1.92)
0.171
1.31 (0.88–1.95)
0.191
Exercise (per week)
0
1 (Ref)
1 (Ref)
1–2
1.42 (1.03–1.98)
0.034
1.43 (1.02–2.01)
0.041
≥3
1.63 (1.17–2.26)
0.004
1.57 (1.12–2.20)
0.009
Body mass index (kg/m2)
<23.0
1 (Ref)
1 (Ref)
23.0–24.9
1.36 (0.91–2.04)
0.135
1.25 (0.82–1.91)
0.308
≥25.0
1.22 (0.86–1.73)
0.261
1.01 (0.69–1.46)
0.966
Variable
Age, sex-adjusted
Multivariate*
OR (95% CI)
P-value
OR (95% CI)
P-value
No. of antihypertensive medication classes
1
1 (Ref)
1 (Ref)
2
1.47 (1.10–1.96)
0.009
1.55 (1.14–2.12)
0.005
≥3
4.07 (2.25–7.36)
<0.001
3.82 (2.06–7.10)
<0.001
Habitual high salt intake†
No
1 (Ref)
1 (Ref)
Yes
0.60 (0.45–0.80)
<0.001
0.64 (0.48–0.67)
0.004
Concomitant medication for diabetes
No
1 (Ref)
1 (Ref)
Yes
1.77 (1.25–2.50)
0.001
1.67 (1.16–2.40)
0.006
Concomitant medication for dyslipidemia
No
1 (Ref)
1 (Ref)
Yes
1.45 (1.11–1.89)
0.006
1.48 (1.12–1.97)
0.006
Family history of hypertension
No
1 (Ref)
1 (Ref)
Yes
1.66 (1.27–2.18)
<0.001
1.72 (1.29–2.30)
<0.001
Family history of cardiovascular disease
No
1 (Ref)
1 (Ref)
Yes
1.70 (1.23–2.35)
0.001
1.70 (1.21–2.39)
0.002
Table 1. Baseline characteristics of the study population (n=1,523)
KRW, Korean won.
Monthly income in million KRW or 1,000 US dollar.
Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for women and men over 65 years of age.
Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12); high intake was defined as a total score ≥18 for men and ≥16 for women.
Table 2. Comparison of demographic and lifestyle factors between the adherent and nonadherent groups
Values are presented as number (%).
KRW, Korean won.
Adherence was calculated using the pill count method. Adherence ratio (%)={(number of prescribed pills−number of residual pills)/number of prescribed pills}×100. We defined good and poor adherence as an adherence ratio ≥0.80 and <0.80, respectively.
P-values calculated using the t-test for continuous variables or the chi-square test for categorical variables.
Monthly income in million KRW or 1,000 US dollars.
Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for women and men over 65 years of age.
Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12) and high intake was defined as a total score ≥18 for men and ≥16 for women.
Table 3. Association of sociodemographic and lifestyle factors with adherence to antihypertensive medication
Logistic regression analysis was conducted after adjusting for age, sex, monthly income, and exercise frequency.
Monthly income in million KRW or 1,000 US dollars.
Moderate alcohol consumption was defined as 8 standard glasses or less per week for men under 65 years of age and 4 standard glasses or less per week for women and men over 65 years of age. High-risk alcohol consumption was defined as more than 8 standard glasses per week for men under 65 years of age and more than 4 standard glasses per week for woman and men over 65 years of age.
Table 4. Association between hypertension-related factors and adherence to antihypertensive medication
R2=6.323 (Hosmer-Lemeshow), P=0.611.
OR, odds ratio; CI, confidence interval; Ref, reference.
Logistic regression analysis adjusted for age, sex, monthly income, and exercise frequency.
Habit of salt intake was evaluated with 3 questionnaires (scoring system of 0 to 12). High intake was defined as a total score of ≥18 for men and ≥16 for women.